Is it Apt to Retain Haemonetics Stock in Your Portfolio Now?

HAE's Hospital rebound and rising NexSys PCS adoption boost growth prospects despite FX and solvency pressures.

Zacks Investment Research • Dec 12, 2025

Why Haemonetics (HAE) is a Top Growth Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Investment Research • Dec 3, 2025

Top 2 Health Care Stocks You May Want To Dump This Month

As of Dec. 2, 2025, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Benzinga • Dec 2, 2025

Touchstone Small Company Fund Q3 2025 Performance Review

The Touchstone Small Company Fund underperformed its benchmark, the Russell 2000 Index, for the quarter ended September 30, 2025. Among the Fund's top-performing sectors in terms of adding value were Financials and Consumer Staples. From a factor perspective, the Fund's focus on profitable, liquid, and higher quality small cap stocks negatively impacted relative performance during the quarter.

Seeking Alpha • Nov 27, 2025

Touchstone Small Cap Fund Q3 2025 Contributors And Detractors

Among the largest contributors to Fund performance were Armstrong World Industries, Ingevity Corporation, and Graham Holdings Co. Graham Holdings outperformed the benchmark on strong second quarter results, led by solid growth in Kaplan Education and the continued expansion of its Healthcare segment. Among the largest detractors from Fund performance were Interparfums, Haemonetics Corporation, and White Mountains Insurance Group.

Seeking Alpha • Nov 26, 2025

Interpreting Haemonetics (HAE) International Revenue Trends

Review Haemonetics' (HAE) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.

Zacks Investment Research • Nov 17, 2025

Here's Why Haemonetics (HAE) is a Strong Growth Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Investment Research • Nov 14, 2025

Why Haemonetics (HAE) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Investment Research • Nov 13, 2025

Haemonetics (HAE) is a Top-Ranked Value Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Investment Research • Nov 11, 2025

SG Capital Dumps Nearly 732,000 Haemonetics Shares Worth $59.1 Million

SG Capital sold 731,892 shares of Haemonetics. The investment firm currently holds 175,000 shares.

The Motley Fool • Nov 8, 2025